Effect of trimetazidine on incidence of major adverse cardiac events in coronary artery disease patients undergoing percutaneous coronary intervention: A protocol for systematic review and meta-analysis

BACKGROUND: Percutaneous coronary intervention (PCI) is a common treatment method for coronary artery disease (CAD). PCI can cause myocardial ischemia or injury, and lead to major adverse cardiac events (MACEs). Trimetazidine has significant cardioprotective effects and improves endothelial dysfunct...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Kun, Zheng, Yu-shui, Fang, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598800/
https://www.ncbi.nlm.nih.gov/pubmed/33126352
http://dx.doi.org/10.1097/MD.0000000000022918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598800/
https://www.ncbi.nlm.nih.gov/pubmed/33126352
http://dx.doi.org/10.1097/MD.0000000000022918

Ejemplares similares